Starling Oncology STLN
NASDAQ STLN
$6.47 -0.04 (-0.54%)
As of: Sep 30, 2026 · 1:56 PM EDT

Starling Oncology, Inc. (STLN) Deferred Taxes (2021 - 2023)

Updated

Starling Oncology (STLN) posted Deferred Taxes of -$32,000 for FY2025.

Analysis

Starling Oncology, Inc. (STLN) Deferred Taxes (2021 - 2023) Analysis & Trends

Since FY2020, Starling Oncology has reported Deferred Taxes for 5 years.

  • The FY2025 figure stands as the highest annual Deferred Taxes in data going back to FY2020.
  • Business Quant data shows STLN's Deferred Taxes at -$76,000 in FY2023, -$263,000 in FY2022 and -$1.24 million in FY2021.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -126,000.00
Sep 30, 2023 80,000.00
Jun 30, 2023 -4,000.00
Mar 31, 2023 -26,000.00
Dec 31, 2022 -446,000.00
Sep 30, 2022 52,000.00
Jun 30, 2022 -49,000.00
Mar 31, 2022 180,000.00
Dec 31, 2021 2.30 Mn
Sep 30, 2021 -3.76 Mn
Mar 31, 2021 221,000.00
API Access

Starling Oncology, Inc. Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=STLN&period=max&api_key=YOUR_API_KEY